From: The immunosignature of canine lymphoma: characterization and diagnostic application
 |  |  |  | Portion of the signature decreasing by 3 months2 | Portion of signature returning to pretreatment Levels at relapse3 | ||||
---|---|---|---|---|---|---|---|---|---|
Individual | Type4 | DFI (days)5 | Peptides6 | Number7 | Percent8 | Median fold change at day 90 | Number | Percent | Median fold change vs day 0 |
247690 | B | 174 | 3 | 0 | 0 | 1.21 | 0 | 0 | 0.78 |
248661 | B | 280 | 5 | 1 | 20 | 0.85 | 0 | 0 | 0.59 |
251332 | B | 273 | 10 | 7 | 70 | 0.59 | 0 | 0 | 0.42 |
251661 | B | 119 | 71 | 65 | 92 | 0.42 | 5 | 7 | 0.37 |
252343 | B | 257 | 11 | 9 | 82 | 0.46 | 1 | 9 | 0.49 |
253509 | B | 270 | 7 | 7 | 100 | 0.45 | 0 | 0 | 0.20 |
256744 | B | 112 | 3 | 1 | 33 | 0.87 | 1 | 33 | 0.94 |
257195 | B | 333 | 4 | 3 | 75 | 0.69 | 1 | 25 | 0.45 |
219623 | T | 185 | 2 | 1 | 50 | 0.78 | 1 | 50 | 0.95 |
238300 | T | 167 | 5 | 4 | 80 | 0.54 | 0 | 0 | 0.49 |
243388 | T | 270 | 3 | 3 | 100 | 0.37 | 3 | 100 | 1.42 |
251702 | T | 71 | 6 | 0 | 0 | 1.37 | 0 | 0 | 1.40 |